Vent Creativity, a medical technology company focused on AI-driven surgical planning solutions, has announced the appointment of Paul Abrams as Vice President of Sales. In this role, Abrams will be responsible for leading commercial operations and driving broader adoption of the company’s digital twin technology as it continues to expand within orthopedic surgery markets.
Health Technology Insights: AHN Offers Innovative Low-Dose Radiation Therapy for Osteoarthritis
The company’s platform allows surgeons to develop a highly detailed, patient-specific digital model of the knee prior to surgery. By offering deeper visibility into factors such as ligament balance and bone quality, the software helps clinicians prepare more effectively before entering the operating room. Designed to work alongside existing surgical systems, the technology supports more confident decision-making and smoother procedural planning without disrupting current workflows.
Abrams joins Vent Creativity with more than three decades of experience across healthcare, medical devices, and software-based technologies. Throughout his career, he has led sales organizations through periods of early adoption and sustained growth. His experience includes building scalable commercial teams, positioning complex clinical innovations in clear and practical terms, and helping emerging technologies gain traction in competitive healthcare environments.
Health Technology Insights: NeuraLight Unveils Scientific Leaders Advancing Neurology
Gokce Gilly Yildirim, Chief Executive Officer of Vent Creativity, said that Abrams brings the right combination of commercial rigor and healthcare insight at a pivotal point in the company’s development. She noted that his understanding of how clinical benefits connect with hospital priorities and surgeon workflows will be essential as Vent Creativity works to expand across health systems and ambulatory surgical centers.
As Vice President of Sales, Abrams will collaborate closely with leadership, clinical experts, and engineering teams to shape a structured go-to-market approach. His responsibilities will include refining how the platform’s value is communicated to surgeons and healthcare organizations, as well as establishing the commercial processes needed to support sustainable, long-term growth.
Abrams said he was drawn to Vent Creativity’s focus on addressing a meaningful clinical challenge. He shared that providing surgeons with clearer insight before surgery can directly impact confidence and outcomes. According to Abrams, the next phase for the company is centered on disciplined execution and aligning the technology’s clinical advantages with a focused commercial strategy that supports adoption at scale.
With Abrams joining the leadership team, Vent Creativity plans to accelerate market penetration and further strengthen its position as a reliable surgical planning partner for orthopedic surgeons and healthcare providers worldwide.
Health Technology Insights: Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
